申请人:Mitsubishi Pharma Corporation
公开号:EP1256581A1
公开(公告)日:2002-11-13
The compound of the following formula:
wherein R1 and R2 independently represent a hydrogen atom or a lower alkyl group; A represents a group selected from the group consisting of 1-azabicyclo[3.2.2]nonyl group, 1-azabicyclo[2.2.2]octyl group, or an N-oxide thereof, or a pharmaceutically acceptable salt thereof or a hydrate thereof has both improving effect on enterokinetic functions and suppressing effect on acid secretion, and also is highly safe. Accordingly, the substance is useful as preventive or therapeutic medicament for a gastroesophageal reflux disease.
下式的化合物:
其中 R1 和 R2 分别代表氢原子或低级烷基;A 代表选自 1-氮杂双环[3.2.2]壬基、1-氮杂双环[2.2.2]辛基或其 N-氧化物组成的组,或其药学上可接受的盐或其水合物,具有改善肠动力功能和抑制胃酸分泌的作用,而且安全性高。因此,该物质可用作胃食管反流病的预防或治疗药物。